ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267268.1	Tanespimycin	Chronic Lymphocytic Leukemia	0.044163414	Resistant
ENSG00000267268.1	Tanespimycin	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.029968892	Sensitive